血蛋白质学用于克罗恩病和性结肠炎的风险预测和治疗目标发现
Xiaoqin Gan1, Yanjun Zhang1, Yuanyuan Zhang1
1Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Multi-organ Injury Prevention and Treatment, Guangdong Provincial Institute of Nephrology, Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou 510515, China.
这项研究确定了与克罗恩病 (CD) 和性结肠炎 (UC) 风险相关的血蛋白. 这些蛋白质改善了疾病预测,并为炎症性肠病提供了潜在的新药标.
科学领域:
- 胃肠病学 胃肠病学
- 蛋白质组学是指蛋白质组学.
- 遗传学 是一个遗传学.
背景情况:
- 炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),对健康造成重大负担.
- 确定可靠的生物标志物用于IBD的早期检测和风险分层是至关重要的.
研究的目的:
- 识别与发生CD和UC相关的血蛋白.
- 使用蛋白质组数据开发和验证CD和UC风险的预测模型.
- 发现IBD的新型基于蛋白质的治疗点.
主要方法:
- 利用来自英国生物库参与者的血样本 (开发和内部复制集) 和外部验证集的大规模蛋白质基因分析.
- 采用双样本门德尔随机化 (MR) 评估已识别的蛋白质与CD和UC的因果关联.
- 开发并验证基于蛋白质组的风险预测模型,将其性能与传统的临床模型进行比较.
主要成果:
- 分别确定了49个和34个与发生性CD和UC风险显著相关的蛋白质,结果在数据集中复制.
- 核磁共振分析揭示了CD (TIMP1,TNFRSF10A,LTBR) 和UC (CCL20,OSM,NOS2,CD300E) 中特定蛋白质的因果作用.
- 与单独的临床模型相比,蛋白质组模型显著提高了CD和UC风险预测 (外部验证C指数:CD为0.94,UC为0.82)
结论:
- 与CD和UC相关的新型血蛋白,得到遗传证据的支持,代表了潜在的治疗点.
- 血蛋白质组学大大改善了发生CD和UC的风险预测.
- 这些发现为IBD药物发现和个性化风险评估开辟了新的途径.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...


